Reference
Peptide library
Chemical identity and regulatory status, traced to primary records. Each entry cites PubChem for structural data, Drugs@FDA for approvals, and FDA's published compounding tables where a substance appears on them.
14 of 14 compounds
| Compound | Class | Formula | CAS | US regulatory status |
|---|---|---|---|---|
| BPC-157Pentadecapeptide BPC 157, PL-14736 | Synthetic 15-residue peptide corresponding to a partial sequence of human gastric juice protein BPC | C62H98N16O22 | 137525-51-0 | Unapproved |
| TB-500Thymosin beta-4 fragment (LKKTETQ), Ac-LKKTETQ-OH | Synthetic acetylated heptapeptide corresponding to the actin-binding region of thymosin beta-4 (residues 17–23) | C38H68N10O14 | 885340-08-9 | Unapproved |
| SemaglutideOzempic, Wegovy | GLP-1 receptor agonist (acylated GLP-1 analogue) | C187H291N45O59 | 910463-68-2 | Approved |
| TirzepatideMounjaro, Zepbound | Dual GIP and GLP-1 receptor agonist | C225H348N48O68 | 2023788-19-2 | Approved |
| IpamorelinNNC 26-0161, Ipamorelin acetate | Growth hormone secretagogue | C38H49N9O5 | 170851-70-4 | Category 2 |
| CJC-1295CJC-1295 DAC, DAC:GRF | Growth hormone-releasing hormone (GHRH) analogue | With DAC: C165H269N47O46 | With DAC: 446262-90-4 | Unapproved |
| SermorelinGeref, GRF(1-29)NH2 | GHRH analogue — human GHRH (1-29) amide | C149H246N44O42S | 86168-78-7 | Discontinued |
| GHK-CuCopper tripeptide-1, Prezatide copper | Copper(II) complex of the tripeptide glycyl-L-histidyl-L-lysine | C14H23CuN6O4+ (prezatide copper, PubChem CID 71587328) | 89030-95-5 (copper complex) | Unapproved |
| Thymosin alpha-1Thymalfasin, Tα1 | Synthetic 28-residue N-acetylated peptide corresponding to the N-terminal fragment of prothymosin alpha | C129H215N33O55 | 62304-98-7 | Unapproved |
| Melanotan IIMT-II, MTII | Cyclic heptapeptide | C50H69N15O9 | 121062-08-6 | Unapproved |
| BremelanotidePT-141, Vyleesi | Cyclic heptapeptide melanocortin receptor agonist | C50H68N14O10 | 189691-06-3 | Approved |
| TesamorelinEgrifta, TH9507 | Stabilised GHRH analogue — human GHRH(1-44) amide, N-terminally acylated | C221H366N72O67S | 218949-48-5 | Approved |
| SelankTP-7, Selank acetate | Synthetic heptapeptide | C33H57N11O9 | 129954-34-3 | Unapproved |
| EpitalonEpithalon, AEDG peptide | Synthetic tetrapeptide | C14H22N4O9 | 307297-39-8 | Unapproved |
These records describe what a compound is and how it is classified. They do not describe effects, uses, protocols or outcomes, and regulatory status is not a safety assessment. Where authoritative sources disagree — and for several of these compounds they do — the disagreement is recorded on the compound page rather than resolved silently.